Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast
- PMID: 20062080
- PMCID: PMC2845730
- DOI: 10.1038/onc.2009.463
Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast
Abstract
Breast carcinoma invasion is associated with prominent alterations in stromal fibroblasts. Carcinoma-associated fibroblasts (CAF) support and promote tumorigenesis, whereas normal mammary fibroblasts (NF) are thought to suppress tumor progression. Little is known about the difference in gene expression between CAF and NF or the patient-to-patient variability in gene expression. Paired CAF and NF were isolated from six primary human breast carcinoma specimens. RNA was extracted from low-passage cultures of CAF and NF and analyzed with Affymetrix Human Genome U133 Plus 2.0 arrays. The array data were examined with an empirical Bayes model and filtered according to the posterior probability of equivalent expression and fold difference in expression. Twenty-one genes (27 probe sets) were up-regulated in CAF, as compared with NF. Known functions of these genes relate to paracrine or intracellular signaling, transcriptional regulation, extracellular matrix and cell adhesion/migration. Ten genes (14 probe sets) were down-regulated in CAF, including the pluripotency transcription factor KLF4. Quantitative RT-PCR analysis of 10 genes validated the array results. Immunohistochemical staining for three gene products confirmed stromal expression in terms of location and relative quantity. Surprisingly, the variability of gene expression was slightly higher in NF than in CAF, suggesting inter-individual heterogeneity of normal stroma.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2845730/bin/nihms160300f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2845730/bin/nihms160300f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2845730/bin/nihms160300f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2845730/bin/nihms160300f4.gif)
Similar articles
-
MMP1 and MMP11 Expression in Peripheral Blood Mononuclear Cells upon Their Interaction with Breast Cancer Cells and Fibroblasts.Int J Mol Sci. 2020 Dec 31;22(1):371. doi: 10.3390/ijms22010371. Int J Mol Sci. 2020. PMID: 33396463 Free PMC article.
-
Prognostic relevance of cancer-associated fibroblasts in human cancer.Semin Cancer Biol. 2014 Apr;25:61-8. doi: 10.1016/j.semcancer.2014.02.006. Epub 2014 Feb 19. Semin Cancer Biol. 2014. PMID: 24560651 Review.
-
Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic.J Pathol. 2013 Dec;231(4):457-65. doi: 10.1002/path.4256. J Pathol. 2013. PMID: 24009142 Free PMC article.
-
Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions.Semin Cell Dev Biol. 2010 Feb;21(1):66-71. doi: 10.1016/j.semcdb.2009.11.013. Epub 2009 Nov 28. Semin Cell Dev Biol. 2010. PMID: 19931629 Free PMC article. Review.
-
Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.Am J Pathol. 2009 Mar;174(3):746-61. doi: 10.2353/ajpath.2009.080658. Am J Pathol. 2009. PMID: 19234134 Free PMC article.
Cited by
-
Tubulointerstitial nephritis antigen-like 1 from cancer-associated fibroblasts contribute to the progression of diffuse-type gastric cancers through the interaction with integrin β1.J Transl Med. 2024 Feb 14;22(1):154. doi: 10.1186/s12967-024-04963-9. J Transl Med. 2024. PMID: 38355577 Free PMC article.
-
Tumor Suppression by Anti-Fibroblast Activation Protein Near-Infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts.Cancers (Basel). 2024 Jan 20;16(2):449. doi: 10.3390/cancers16020449. Cancers (Basel). 2024. PMID: 38275890 Free PMC article.
-
Exploration of cancer associated fibroblasts phenotypes in the tumor microenvironment of classical and pleomorphic Invasive Lobular Carcinoma.Front Oncol. 2023 Dec 21;13:1281650. doi: 10.3389/fonc.2023.1281650. eCollection 2023. Front Oncol. 2023. PMID: 38192631 Free PMC article.
-
Identification of potential diagnostic and prognostic biomarkers for breast cancer based on gene expression omnibus.World J Clin Cases. 2023 Sep 26;11(27):6344-6362. doi: 10.12998/wjcc.v11.i27.6344. World J Clin Cases. 2023. PMID: 37900246 Free PMC article.
-
Biological differences between normal and cancer-associated fibroblasts in breast cancer.Heliyon. 2023 Sep 6;9(9):e19803. doi: 10.1016/j.heliyon.2023.e19803. eCollection 2023 Sep. Heliyon. 2023. PMID: 37810030 Free PMC article.
References
-
- Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004;6:17–32. - PubMed
-
- Campbell IG, Qiu W, Polyak K, Haviv I. Breast-cancer stromal cells with TP53 mutations. N Engl J Med. 2008;358:1634–5. author reply 1636. - PubMed
-
- Casey T, Bond J, Tighe S, Hunter T, Lintault L, Patel O, et al. Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer. Breast Cancer Res Treat 2008 - PubMed
-
- Chang CF, Westbrook R, Ma J, Cao D. Transforming growth factor-beta signaling in breast cancer. Front Biosci. 2007;12:4393–401. - PubMed
-
- de Jong JS, van Diest PJ, van der Valk P, Baak JP. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops. J Pathol. 1998;184:44–52. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous